ABSTRACT. We recently identified a female leprechaun infant with marked hyperinsulinemia [as high a s 10,975 pU/ml (78,746 pmol/liter)], presumably secondary to insulin resistance. She had two physical findings suggestive of possible insulin action: cystic ovarian enlargement with gonadotropin-independent steroid secretion and persistent, severe myocardial hypertrophy. To examine the pathophysiology of this disorder we measured the in vitro sensitivity to insulin and other growth factors of erythroid progenitors and a T-lymphoblast cell line derived from her peripheral blood. Resistance to insulin was demonstrated by failure of her circulating erythroid progenitor cells to augment proliferation in response to physiologic concentrations of insulin (1-10 ng/ml). An immortalized T lymphoblast cell line was established bv transforming the cells with the human retrovirus human"I' cell leukemia virus 11. This cell line showed little or no response to physiologic concentrations of insulin contrary to consistently observed stimulation of colony formation by cell lines similarly derived from normals. 'l'he patient's 'I' lymphoblasts, however, showed normal sensitivity to insulin-like growth factor I. I n responsc to supraphysiologic insulin conccntrations (25-1000 ng/ml), leprechaun 'I' lymphoblasts showed significant augmentation of colony formation (peak 189% above baseline a t 50 ng/ml); normal 'I' lymphoblasts also showed responsiveness at these high insulin concentrations. Preincubation with a monoclonal antibody against the insulin-like growth factor I receptor (uIK-3 at 5000 ng/ml) blocked the in vitro effect of physiologic concentrations of insulin-like growth factor and supraphysiologic concentrations of insulin on leprechaun and control 1' lymphoblast colony formation, but had no clear effect upon the response to physiologic insulin concentrations. These findings document genetic insulin resistance in hematopoietic cells from a patient with leprechaunism. Response to supraphysiologic concentrations of insulin appears to be mediated via the insulin-like growth factor receptor mechanism which remains intact. Such action in vivo could account for the ovarian and cardiac findings in the patient.
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Leprechaunism (Donahue's syndrome) is a rare disorder characterized clinically by intrauterine and postnatal growth retardation, diminished fat and muscle tissue, characteristic facies, precocious puberty, and early death (I). The most common physiologic disturbance in this condition, however, is hyperinsulinism due to severe insulin resistance (2) . While leprechaunism has been described in approximately 30 patients, only limited studies of the mechanism of the insulin resistance have been reported (3) . Both insulin receptor and postreceptor defects have been proposed to account for the insulin resistance in different patients. Previous investigators have found persistence of the insulin resistance in cultured cells suggesting a primary genetic basis for the reduced insulin sensitivity.
We describe herein a patient with leprechaunism with marked hyperinsulinemia and many of the classical phenotypic features of the leprechaun state. There were two unusual physical findings: large, autonomously functioning, polycystic ovaries and persistent, diffuse, severe myocardial hypertrophy, abnormalities likely to be associated with insulin action. Using clonogenic assays employing both freshly isolated BFU-E (4-9) and HTLV-I1 transformed T-LB cells (10. 1 I), we demonstrated in vitro responses only at supraphysiologic concentrations of added in-
sulin. This activity was completeiy blocked by pretreatment with antibody to the IGF-I receptor suggesting that the observed insulin action was mediated through the IGF-I receptor. Such a mechanism could account for the ovarian and cardiac findings in this and other leprechaun patients.
CASE REPORT
The patient was a 1480 g, 38 cm (50th centile for 30 wk gestation) female product of a term gestation born to a 19-yr-old 1;ilipinc l'cmalc (<i2.i'O,'I'AI3 I ). 'l'hc patient's filthcr is black and unrclatcd to her rnothcr-.
At birth, the child was notcd to have severe intrauterine gro\\th retardation associated with depleted subcutaneous and muscle tissuc. Shc also had peculiar lircie\ cliaracteri/cd 1)) a dcprcsscd nasal bridge. undcrtlc\clopcd pcriorbital bonk structures. postcriorly rotated arid downw:irdl) displaced pinnac w~t h ~rndcrdc-vcloped superior hcllces. a right prcauricular skin tag. L I~~L I I . I I~~ narcs. a very br-oad ~rppcr-lip with a ~c r ! thin \,errnilion borderand undcrdcvclopcd plliltrurn, ;lr~d : I high-arched p:ilate. A shor-t. ~nidsystolic mur-mur at the the lower left ster-nal border-radiatirlg to the back, protuber-ant nipl,lcs. diff'usc hypcrtrichosis. arid a prominent clitol-is also wcl-c notcd. A specific y n d r o n i e \\.as not idcntificd at this timc. I hc kar)ot)pe w:rs 46XX. ('ar-drologic evaluation. ineltiding ccliocar-tiiograrn. Mas consistent \\itti diff'usc rnyocar-dial Iiyper-11-ophg .
At age 1.25 months. ltec per-itoncal air-was notcd o n a I-atiiogl-aph ol' tllc :tl>dorncn. hut I:~parotom> tiiilctf to r-e\eal :In! bowel pcrk)ration. Ilo\vcver-. the o~a r i c s wcrc notcti to he quite cnlar-gcd (rnax~rnal diameter \+as 0-8 ern o n the left and 5-0 cn1 on the right) anti contained rnultiplc fi)llicular-c!,st5. scl>aratcd from each other 11) septa 01' normal strom:~l tissue.
At age 3.5 months. the patient first tieveloped intermittent hypcl.glyccrnia and Iiqpogl>ccmia arld the diagnosis of' Icpr-cchaunism w:rs entertained. A serum insulin level was 2044 ml (14.t100 pmol/litcr). A simultaneous ( ' pcptidc le\.cl \\.:is 45 ng/ml (norrnal stimul:itcd Ic\,cl = I .5-0.0 ng/rnl). Plasma glucose Icvcls ranged h e t~c c n 3X :tnd 144 11g/til (2.09 and 7.0.3 mmol/ liter). Sornatomcdin-(' \\as 4). 10 1 J/ml (normal for age 0.17-0.02 l!/n11) and glycosglatcd hemoglobin w:rs 3.5:; (norriral 4-7%). I'clvic ultr-asound I-cvcalcd per-sistcncc of'b~later:il o\:ir-ran cnlargcrncnt ( I .S x I x 3 c m on the right and 2 ern In gr-eatcst diameter or1 the Icfi) \bit11 both o\arics containing small ~1 s t~. Serum I .I I was 5 I1 J/litcr (normal l'or age <2-70 I li/liter-). l.SI 1 3 IlJ/litcr-(normal for-age <?-4 11!/1.). anti cstradrol 7 pg/ml (75.7 pmol/litcr: normal CII-age <30 pg/rnl. < I I0 [,mollliter-). I'crsistcrlcc of' significant tiitti~\c m!ocardial h>.pcr-11-oph> \\as notcd.
At age 5.5 months hilateral 1>1-cast development ( l anncr-I l l ) was notcd li~r-the lirst tinic without other-evidence ol'estrogen clt'cct. A pelvic ~~ltrasonogr:~rli again slio\vcd brlatcr-all) enlarged ovaries. I3:lsal 1.1 1 u a s 2.5 Il!/liter-. I-Sl I < I Ill/l~tcr. estr-adiol I X O [>g/r111 (Oh prnol/litcr-: nor-nlal h r age <3O pg/mI. < I I0 ~lrllol/litel~). cstr-or1e 72 ~>g/llll (llor-lll:ll I ; ) ! -age < I0 ~>g/llll): :111ci tcstostcronc 0.70 ng/ml (1.03 rin~ol/litcr: rlor-ma1 for age 4) . I0 rrg/rnl: <0.35 nmol/lrtcr). I.ollonirig a 100-pg intr-a\.cnous t~olu\ of l.li1; thcrc was n o \rgnilicant irlcr-case ol'scr~um L.i1 or-I.SI1 concentrations o\cr. hirsal Ic.\eIs. In arl attcrnpt to cori(r.ol tlic hypoglycemia \r hich onl) I-csponcied to lkcding c\.cr-! 2 11. tiia-/oxide ( 5 rng/kg/da! ) \vas hegun. 'I he scr-urn insulin It\ el t~cf'or-c dia/oxitic was lO.075 plI/nil (78.746 pmol/liter), Ii!pcr-gl!ccriiia ensued and responclcii to orliission ol' dia/oxidc fi)r-13 h l lie dia/oxidc \\,as r c s~~r~a i and ultimatcl\ incrc:~scd to I0 riiel'l\li/ L , < day bccausc ol'thc I-ecirr-rcnec ol'l~ypogl!ccrnia: the serum irisulin lcvcl 3 \vk I;I~cI. \v;is 1 I7 plJ/rirl (840 pmol/liter-). I h r o~~g l i o~t this timc limitcci gr-o,u!!r n a s rlotcd. Subscc~uentl>. tlie lilriiil\ moved t o ariothcl-state' \ \ h c~-c thc l>ahh died at 7 month\ ol'agc. At autol)sb. thcr-c was a ~iorrnal-si/ed parlcrca5 L\ ith mar-Led 15lct-ccll hyper-pl:rsia (~mmunohistoclicmical staining positi\.c fiir insulin), notlular rcgcncr-:ition in the lilcr. a high-lyrnglicmorrhagrc lcfi ovi~r-y. an cnlal-gcd [right oval-!. rn!ocardral fihr-il h!pcr-tr-o~~h!. cortical hrain atroplr!,. and :I 7.0-em pineal c>st. Yo specific cause ol'tlcatli w:is lb~rnd.
I'cilic,tl/.\. I lematopoict~c cclls were obtarncd li.on~ the per-iphcr-al l~lood o f t h c leprcch:t~rr~ when sllc h a \ 4 months old. ('ontrol data for-the 131.11-ii and 'I' I!mpliohlast cell line c\pc~-imcnts were dcrrvcd li-om pools ofriormal adults. including sc\en males. 150 ? 2.6% above baseline occuning at 5 ng/ml of added insulin. The addition of any insulin caused less proliferation of leprechaun BFU-E than in plates without added insulin, a phenomenon previously observed in some obese subjects (8) . Leprechaun BFU-E showed some augmentation of colony formation in response to IGF-I (1 15% above baseline) albeit less than either control group (Fig. 1, center) ; mean peak augmentation in 16 expenments with adult BFU-E was 185 + 8.4% above baseline occumng at 8 ng/ml of added IGF-I and in 14 experiments with BFU-E from infants and children, mean peak stimulation was 159 t 9.8% above baseline occurring at 6 ng/ml of added IGF-I. Leprechaun BFU-E also showed decreased G H responsiveness (1 30% above baseline) compared to both control groups (Fig. I ,  right) ; in 15 experiments with adult BFU-E, mean peak augmentation was 16 1 + 3.1 % above baseline occurring at 200 ng/ml of added GH and in 15 experiments with BFU-E from infants and children, mean peak stimulation was 165 & 3.3% above baseline occurring at 50 ng/ml of added GH. Clonogenicstimulation oftransformed T-LB. As with the BFU-E, leprechaun T-LB (mean of 15 experiments) showed no augmentation of colony formation in response to insulin concentrations up to 9 ng/ml (Fig. 2, left) . Minimal responsiveness was observed at 10 ng/ml. Significant proliferation was consistently seen at concentrations of insulin above 10 ng/ml with a mean peak augmentation of 193 ? 15% above baseline occurring at 50 ng/ml. Control transformed infant T-LB (mean of eight experiments) also showed augmented proliferation of both physiologic and supraphysiologic insulin concentrations. Control adult T-LB showed stimulation as high as 139% above baseline at 250 ng/ml of added insulin (in five of 10 experiments). Peak responsiveness of leprechaun T-LB to IGF-I (150 t_ 9.3%) (Fig.  2 , cmler, mean of 10 experiments) was within two standard deviations of mean responses of control cells (five infant and 7 adult experiments for IGF-I). Peak responsiveness of leprechaun T-LB to G H (133 + 6.7%) (Fig. 2, right , mean of eight experiments) was normal compared to adult controls (mean of six expenments) and slightly decreased compared to infant controls (mean of three experiments).
T-LB proliferation after nIR-3 prelreatmenl. No augmentation of either leprechaun or control T-LB colony proliferation was seen in response to nIR-3 alone (at concentrations between 50-5000 ng/ml, data not shown). Using IGF-I concentrations of I-10 ng/ml, 500 ng/ml of nIR-3 partially blocked and 5000 ng/ml totally blocked augmentation of leprechaun (Fig. 3, left) and adult control (Fig. 3, center) T-LB colony formation. Infant control T-LB (Fig. 3, right) showed significantly but not completely blocked colony augmentation in response to 5000 ng/ml of aIR-3.
To examine whether the augmenting effect of supraphysiologic insulin concentrations upon leprechaun and control T-LB growth might be due to stimulation through the IGF-I receptor, the responsiveness of T-LB was evaluated after pretreatment with nIR-3 (Fig. 4) . Since the early peak augmentation of proliferation of T-LB generally occurs at added insulin concentrations of 7-9 ng/ml and the late peak between 100-500 ng/ml, the effect of aIR-3 pretreatment was tested at these concentrations of added insulin. Although no concentration of aIR-3 completely blocked the augmenting effect of insulin at 7 ng/ml of insulin, increasing Using o1 r1liro clonogcnic bioassays. wc havc documented neal--complete resistance to physiologic concentrations of'insulin in a newly described leprechaun inlint. Absent augnicntation ol Rf-lJ-1: colong fiir-mation h q insulin could still rellect it1 1.11.0 environmental inlluenccs since the 13I:lJ-E represent a primas) tissue explant. O n the other hand, because the virally transfornicd 7J'-1ymphoblast cell line 1s 11i;ln~ gcncr;~tions removeti from the in 1~1~0 environment, the signilicantlq blunted response of these cells to physiologic insulin concentrations must reflect gcncticall> programed insulin resistance. 'The snccificitv of the insulin re-. -sistancc is sugested by the presence of normal rcsponsivcncss to Ic;I~-l.
I>etailcd evaluation oftlic mechanism o f t h e insulin resistance in leprechaunisr-n has been attempted in on11 four-prc\ious patients. 'l'hc most cxtcnsivcly studied patient. Arkansas I (AI-k-I), liad variable lindings. including normal insulin binding to monocytcs and cultured libroblasts ( 1 8 ) . decreased insulin hind-;rig to rnorioq.tc5 ( l 9). er! tliroc! tcs (10) . and cultur-cd lihr-ol>last\ (7 I ). and increased binding allinit! \\it11 decl-cascti sensiti\ it! of' binding to altcr:~tions in 111-1 and tcrnperatilrc using I:l3-\.iru\-transformed R-Iymphoc! tcs ( 2 2 . 73). More rccentl!. 1:lsas ( ' I (11.
(7) reexamined cultured fibroblasts I'rom this patient and fbund no high-atlinit) insulin binding anti normal lev-attinit! t~inding (2) . 111 contrast. another lcprechau~i Ixrtlcnt. M'i~irlipcg,/NI f 1. \\a repor-ted to h a \ c a >SOr; reduction in insulin binding to cultur-cd fit31-oblasts (3. 24). Insulin-stimulated g l~~c o s c incor1)oration \\.:IS markcdl) blunted. but insulin-rnedialcd rnctli!~l-AIl3 uptakc \ v a nol-ma1 in thi\ patient's lihrohlasts. I'hesc rcsults \\.crc ncarl! identical ~v h e n the fibroblasts were csposecl to ICi1:-I. suggcstins that this leprechaun liad a receptor-defect common to thc 110-mologous insulin and 1(;1' -1 receptors i n~o l v i n g couplins of ligand signal fix glucose rncor-por-atiori. but not for rneth~l-AIR uptake. In a third lepr-echaun patient. ('hapel llill. ttic'rc \\:is decreased insulin binding to li\.cr. nornial insulin binding to fibrol~lasts. and blunted fibroblast uptake of both I f I -g l u c~)~ and '11-AIR in response to hoth Insulin and 1Cif:-1 ( 2 5 . 20) .
A fburth Icprechaun. Minncsota/NIl3. had rnor-c than a 00"; reduction in insulin binding to f'B-\.iri~s-t~-ansfor.~iied I3-l!.mpliocytes. pr-csuniably o n the I)asis of decreased ~rcccl~tor nilmt>cr (27). These findings suggest that the Icprccliaun state ma! result fr-om hcterogcncous bioclicmical/molecular-dckcts. While \vc
have not yet defined the molecular basis of the insulin resistance in our patient, e.g. binding, transmembrane-signaling, postreceptor defects, etc., there remains near-total insulin resistance at physiologic concentrations implying that the insulin receptor/ effector mechanism is nonfunctional. Unlike the WinnipeglNIH and Chapel Hill patients, our leprechaun had normal activity of the IGF-I receptor/effector mechanism.
Our findings of significant clonogenic augmentation of T-LB at supraphysiologic concentrations of added insulin, with a dosedependent competitive inhibition of this stimulation by preincubation with the anti-IGF-I-receptor antibody, suggest that insulin action can occur via the IGF-I receptor. The measured serum insulin concentrations in our patient, as high as 459 ng/ ml (78.746 pmol/liter), were in the range in which insulin significantly augmented In vitro T-LB colony formation (25-1000 ng/ml; 4484-179,375 pmol/L). Similarly, Flier et ul. (1 7), using human skin fibroblasts, found that aIR-3 inhibited ['HI thymidine incorporation at insulin concentrations >I000 ng/ml, but not below. These conclusions are consistent with the generally held view that insulin at low (physiologic) concentrations acts in vivo through the insulin receptor predominantly promoting glucose uptake and other metabolic functions, whereas at high concentrations, insulin, acting through the IGF-I receptor, serves as a mitogen, stimulating ['Hlthymidine uptake, DNA synthesis, and cell replication (1 5 , 17).
The unusual clinical findings of persistent, diffuse myocardial hypertrophy and cystic ovaries may be clinical markers of insulin action through the IGF-I receptor. The presence of massive cystic ovarian enlargement and autonomous steroidogenesis (as judged from the flat serum gonadotropin responses on the LRF test) could result from direct insulin action upon the ovary. Fifty percent of previously reported leprechaun infants have had ovarian enlargement. although previously noted prccocious puberty in these patients has been attributed to hypothalamic-pituitary hyperfunction despite normal gonadotropin measurements in several patients (1). IGF-I receptors have been described in normal human ovarian tissue (28). In the swine granulosa cell model (29). stimulation with IGF-I results in production of pregnenolone and progesterone. Adashi et ul. (30) also have reported that highly purified IGF-I (50 ng/ml) induced a 93% increase in ["Slsulfate incorporation into extracellular proteoglycans in a primary culture of rat granulosa cells (30). The constellation of ovarian enlargement, cyst formation, and abnormal steroidogenesis has been noted in other patients with resistance to insulin action upon glucose disposal, e.g. thin women with polycystic ovarian disease and no acanthosis nigricans (9) , patients with type A insulin resistance (3 l), and in uremic individuals (32). The ovarian tissue of one obese woman with polycystic ovarian disease, acanthosis. and marked hyperinsulinemia responded in vitro to stimulation by insulin (500 ng/ml) with production of androstenedione and testosterone (33).
While insulin is known to stimulate myocardial hypertrophy in the infant of the diabetic mother and in the infant with nesidioblastosis (34), the mechanism by which this occurs is unknown. Both insulin and IGF-I receptors have been found in heart and other vascular endothelium (35, 36). It is possible that the significant myocardial hypertrophy observed in our patient and in other leprechauns (1, 25, 27) could result from persistent hyperinsulinemia acting through the IGF-I receptor.
Selective insulin action on some tissues, but not others, in the face of resistance to insulin action on carbohydrate disposal, could be related to the density (and/or affinity) of IGF-I receptors in a given tissue. 
